Aimei Health Technology Statistics
Total Valuation
AFJK has a market cap or net worth of $69.18 million. The enterprise value is $70.38 million.
Important Dates
The last earnings date was Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AFJK has 6.12 million shares outstanding. The number of shares has increased by 251.99% in one year.
| Current Share Class | 6.12M |
| Shares Outstanding | 6.12M |
| Shares Change (YoY) | +251.99% |
| Shares Change (QoQ) | -15.95% |
| Owned by Insiders (%) | 28.18% |
| Owned by Institutions (%) | 57.70% |
| Float | 3.99M |
Valuation Ratios
The trailing PE ratio is 49.44.
| PE Ratio | 49.44 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 39.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -2.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.82% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +7.82% |
| 50-Day Moving Average | 11.22 |
| 200-Day Moving Average | 10.99 |
| Relative Strength Index (RSI) | 63.35 |
| Average Volume (20 Days) | 3,170 |
Short Selling Information
The latest short interest is 99, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 99 |
| Short Previous Month | 80 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.06M |
| Pretax Income | n/a |
| Net Income | 1.80M |
| EBITDA | n/a |
| EBIT | -1.06M |
| Earnings Per Share (EPS) | $0.23 |
Full Income StatementBalance Sheet
The company has $2,138 in cash and $1.21 million in debt, giving a net cash position of -$1.20 million or -$0.20 per share.
| Cash & Cash Equivalents | 2,138 |
| Total Debt | 1.21M |
| Net Cash | -1.20M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | -2.86M |
| Book Value Per Share | -0.47 |
| Working Capital | -2.17M |
Full Balance SheetCash Flow
| Operating Cash Flow | -674,836 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
